Trevena Inc (TRVN)
0.409
+0.03
(+7.35%)
USD |
NASDAQ |
Apr 25, 16:00
0.3842
-0.02
(-6.06%)
After-Hours: 20:00
Trevena Research and Development Expense (Quarterly): 4.173M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.173M |
| September 30, 2023 | 4.26M |
| June 30, 2023 | 3.991M |
| March 31, 2023 | 3.909M |
| December 31, 2022 | 3.395M |
| September 30, 2022 | 5.266M |
| June 30, 2022 | 4.291M |
| March 31, 2022 | 5.259M |
| December 31, 2021 | 3.937M |
| September 30, 2021 | 3.404M |
| June 30, 2021 | 3.449M |
| March 31, 2021 | 2.636M |
| December 31, 2020 | 3.674M |
| September 30, 2020 | 4.301M |
| June 30, 2020 | 2.958M |
| March 31, 2020 | 2.191M |
| December 31, 2019 | 2.861M |
| September 30, 2019 | 5.554M |
| June 30, 2019 | 2.722M |
| March 31, 2019 | 2.154M |
| December 31, 2018 | 2.748M |
| September 30, 2018 | 3.35M |
| June 30, 2018 | 5.128M |
| Date | Value |
|---|---|
| March 31, 2018 | 4.598M |
| December 31, 2017 | 7.198M |
| September 30, 2017 | 10.18M |
| June 30, 2017 | 15.50M |
| March 31, 2017 | 16.10M |
| December 31, 2016 | 31.45M |
| September 30, 2016 | 25.55M |
| June 30, 2016 | 17.20M |
| March 31, 2016 | 15.75M |
| December 31, 2015 | 13.55M |
| September 30, 2015 | 9.650M |
| June 30, 2015 | 10.28M |
| March 31, 2015 | 10.60M |
| December 31, 2014 | 10.88M |
| September 30, 2014 | 13.01M |
| June 30, 2014 | 9.031M |
| March 31, 2014 | 7.634M |
| December 31, 2013 | 6.522M |
| September 30, 2013 | 6.630M |
| June 30, 2013 | 3.495M |
| March 31, 2013 | 2.115M |
| December 31, 2012 | 2.748M |
| September 30, 2012 | 3.397M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.191M
Minimum
Mar 2020
5.554M
Maximum
Sep 2019
3.802M
Average
3.909M
Median
Mar 2023
Research and Development Expense (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.004M |
| Palatin Technologies Inc | 5.554M |
| iBio Inc | 1.535M |
| Theriva Biologics Inc | 4.196M |
| Oragenics Inc | 11.04M |